Looking for a healthcare stock to add to your portfolio? Take a look at Becton Dickenson (BDX) which has provided pharmaceutical products for more than 100 years.
Becton, Dickinson (BD) has completed its merger with C.R. Bard, and the new company is seeing good growth in China and abroad.
Becton Dickenson (BDX) has been in a groove the past five years, and even through a stock market correction the stock keeps doin what it’s been doin.
Becton, Dickinson (BDX) closed out 2017 with profit growth of 15%. Now with the merger of CR Bard, the new company will be a powerhouse in the field of hospital supplies.
The merger between Becton Dickinson (BDX) and C.R. Bard is expected to close in the 4th qtr of this year, and BDX stock is rallying ahead of the big event.